Company: ARTL
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001640334-25-002022
Chunk: 23

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 1
Chunk 23
---
 trials, develop, manufacture and commercialize our product candidates;    ·our ability to raise any current or future funding to meet our capital requirements;    ·the expected timing of the initiation and completion of our clinical studies for our product candidates;    ·the size and growth of the markets for our product candidates;    ·our commercialization, marketing, and manufacturing capabilities and strategies;    ·geopolitical tensions, including tariffs and any war, regional conflict, or acts of terror, that can disrupt investment, supply chains and the economy generally;    ·our ability to compete with companies currently producing alternative treatment methods;    ·the cost, timing and outcomes of any potential litigation involving our product candidates;    ·regulatory developments in the U.S. and internationally;    ·the development, regulatory approval, efficacy and commercialization of competing product candidates;

 ·our ability to attract and retain key scientific or management personnel;    ·the scope of protection we are able to establish and maintain for intellectual property rights covering our products and technology;    ·the terms and conditions of licenses granted to us and our ability to license additional intellectual property related to our product candidates, as appropriate;    ·potential claims related to our intellectual property;    ·the accuracy of our estimates regarding expenses, future revenue, capital requirements and needs for additional financing;    ·our ability to regain and maintain compliance with Nasdaq listing requirements;    ·our ability to develop and maintain our corporate infrastructure, including our internal controls;    ·our cash investment strategy;    ·our ability to develop innovative new product candidates; and    ·our financial performance.

 18Table of Contents

Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. We discuss these risks in greater detail in Part II, Item 1A. “Risk Factors” of this Quarterly Report on Form 10-Q. Given these uncertainties, you should not place undue reliance on these forward-looking statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date of this Quarterly Report on Form 10-Q. We undertake no obligation to publicly update any forward-looking statements, whether as a result